Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · IEX Real-Time Price · USD
7.24
-0.08 (-1.09%)
At close: Jul 19, 2024, 4:00 PM
7.31
+0.07 (0.97%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Amneal Pharmaceuticals Employees
Amneal Pharmaceuticals had 7,700 employees as of December 31, 2023. The number of employees increased by 100 or 1.32% compared to the previous year.
Employees
7,700
Change (1Y)
100
Growth (1Y)
1.32%
Revenue / Employee
$324,059
Profits / Employee
-$21,908
Market Cap
2.23B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 7,700 | 100 | 1.32% |
Dec 31, 2022 | 7,600 | 600 | 8.57% |
Dec 31, 2021 | 7,000 | 1,000 | 16.67% |
Dec 31, 2020 | 6,000 | 500 | 9.09% |
Dec 31, 2019 | 5,500 | -500 | -8.33% |
Dec 31, 2018 | 6,000 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Fortrea Holdings | 19,000 |
AMN Healthcare Services | 18,223 |
Patterson Companies | 7,600 |
QuidelOrtho | 7,100 |
Evolent Health | 4,700 |
CONMED | 4,000 |
Privia Health Group | 1,102 |
Iovance Biotherapeutics | 557 |
AMRX News
- 10 days ago - Amneal to Report Second Quarter 2024 Results on August 9, 2024 - Business Wire
- 12 days ago - Amneal Launches FOCINVEZ™, the First Ready-to-Use Version of Fosaprepitant - Business Wire
- 21 days ago - Amneal Expands Biosimilars Portfolio to Eight Products with Addition of Omalizumab Biosimilar - Business Wire
- 21 days ago - Kashiv BioSciences Enters into Exclusive Licensing Agreement with Amneal for Commercialization of a Proposed Biosimilar to XOLAIR® (Omalizumab) - Business Wire
- 24 days ago - Amneal Releases 2023 Environmental, Social and Governance Report - Business Wire
- 6 weeks ago - Amneal Expands Broad Injectables Portfolio to Over 40 Products with the Addition of Six New Therapies - Business Wire
- 2 months ago - Amneal to Participate at Upcoming Investor Conference - Business Wire
- 2 months ago - Amneal Begins Supplying Over-the-Counter Naloxone Hydrochloride Nasal Spray to U.S. Retail Pharmacies and the State of California - Business Wire